In a breakthrough that could reshape the understanding and treatment of hypertension, researchers have identified a previously overlooked brain mechanism that may play a central role in raising blood pressure.
The discovery, led by scientists at the University of Auckland, points to a small region in the brainstem that links breathing patterns with the regulation of blood vessels.
The brainstem, often described as the most primitive part of the brain, governs essential automatic functions such as breathing, heart rate, and digestion.
Within this region lies the lateral parafacial area, a cluster of neurons now believed to have a surprising influence on blood pressure.
Traditionally, high blood pressure has been associated with factors like diet, lifestyle, genetics, and kidney function.
However, this new research shifts part of the focus toward neural control, suggesting that the brain itself may directly contribute to the condition.
According to the research team, the lateral parafacial region becomes active during forceful exhalation, such as when a person coughs, laughs, or exercises intensely.
Unlike normal breathing, which relies on the lungsβ natural elasticity, these forceful exhalations engage the abdominal muscles.
What makes this finding significant is that the same brain region responsible for controlling these powerful breathing actions also appears to activate nerves that constrict blood vessels. When blood vessels narrow, resistance increases, causing blood pressure to rise.
In laboratory experiments, scientists observed that this region was highly active in subjects with elevated blood pressure. When they deliberately inhibited its activity, blood pressure levels dropped back to normal.
This direct cause-and-effect relationship provides strong evidence that the lateral parafacial region is not just associated with hypertension, but may actively drive it.
The findings also suggest that certain breathing patterns could contribute to chronic high blood pressure.
Individuals who frequently engage abdominal muscles during breathing, whether due to stress, respiratory conditions, or sleep disorders, may unknowingly be triggering this neural pathway.
The study, published in the journal Circulation Research, opens up new possibilities for diagnosing and treating hypertension more precisely.
Instead of focusing solely on symptoms or systemic factors, clinicians may eventually assess breathing patterns as part of cardiovascular evaluation.
However, targeting the brain directly with medication presents challenges. Drugs that act on the brain often affect multiple regions, increasing the risk of side effects. To overcome this, researchers explored an indirect approach.
They discovered that the lateral parafacial region is influenced by signals from the carotid bodies, small sensory structures located in the neck near the carotid arteries.
These bodies monitor oxygen levels in the blood and send signals to the brain to adjust breathing and circulation.
Because carotid bodies are more accessible than brain tissue, they present a safer target for treatment.
By developing drugs that reduce carotid body activity, scientists believe they can indirectly βswitch offβ the overactive brain region responsible for raising blood pressure.
This approach is particularly promising for patients with conditions like sleep apnoea, where breathing repeatedly stops and starts during sleep.
In such cases, carotid body activity increases significantly, potentially overstimulating the brain pathway linked to hypertension.
Researchers are now working with a repurposed drug designed to dampen carotid body signals, with the aim of reducing blood pressure without directly affecting the brain.
While further clinical trials are needed, this discovery marks a significant step forward.
By uncovering a neural trigger behind hypertension, scientists may be moving closer to more targeted, effective, and safer treatments for one of the worldβs most widespread health conditions.
